Simvastatin suppresses dexamethasone-induced secretion of plasminogen activator inhibitor-1 in human bone marrow adipocytes

BMC Musculoskeletal Disorders

Volumn 12, Issue , 2011, Pages

  Sakamoto, Kazutaka ^a   Osaki, Makoto ^a   Hozumi, Akira ^a   Goto, Hisataka ^a   Fukushima, Tatsuya ^a   Baba, Hideo ^a   Shindo, Hiroyuki ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; COLLAGENASE; DEXAMETHASONE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; SIMVASTATIN; ADIPONECTIN, HUMAN; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SERPINE1 PROTEIN, HUMAN;

ADIPOCYTE; ADULT; AGED; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMUR NECK; HIP ARTHROPLASTY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; TIME;

ADIPOCYTES; ADIPONECTIN; AGED; AGED, 80 AND OVER; BONE MARROW CELLS; CELLS, CULTURED; DEXAMETHASONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMUR NECK; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIMVASTATIN; TIME FACTORS;

EID: 79955149043     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-12-82     Document Type: Article

References (40)

1. The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis. CJ Glueck RN Fontaine R Gruppo D Stroop L Sieve-Smith T Tracy P Wang, Clin Orthop Relat Res 1999 366 133 146 (Pubitemid 29439347)
2. Thrombotic and fibrinolytic alterations in the aseptic necrosis of femoral head. E Posan K Szepesi L Gaspar Z Csernatony J Harsfalvi E Ajzner A Toth M Udvardy, Blood Coagul Fibrinolysis 2003 14 243 248 (Pubitemid 36589145)
3. Role of thrombotic and fibrinolytic alterations in the pathogenesis and treatment of osteonecrosis. MA Mont SD Ulrich TM Seyler, J Rheumatol 2007 34 466 468 (Pubitemid 46363998)
4. Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures: mechanism of steroid-induced osteonecrosis. L Yin YB Li YS Wang, Chi Med J 2006 199 581 588 (Pubitemid 43796864)
5. Osteonecrosis in stroke-prone spontaneously hypertensive rats: effect of glucocorticoid. M Murata K Kumagai N Miyata M Osaki H Shindo, J Orthop Sci 2007 12 289 295 (Pubitemid 46835478)
6. Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. MA Kerachian C Seguin EJ Harvey, J Steroid Biochem Mol Biol 2009 114 121 128
7. Vascular injury by glucocorticoid; involvement of apoptosis of endothelial cells. Y Okada T Tanikawa T Iida Y Tanaka, Clin Calcium 2007 17 872 877
8. Bone marrow fat-cell enlargement in early steroid-induced osteonecrosis - a histomorphometric study of autopsy cases. G Motomura T Yamamoto K Miyanishi A Yamashita K Sueishi Y Iwamoto, Pathol Res Pract 2005 200 807 811 (Pubitemid 40220963)
9. Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis. K Miyanishi T Yamamoto T Irisa A Yamashita S Jingushi Y Noguchi Y Iwamoto, Bone 2002 30 185 190 (Pubitemid 34044317)
10. Endocrine functions of adipose tissue. H Waki P Tontonoz, Annu Rev Pathol 2007 2 31 56 (Pubitemid 46448059)
11. The endocrine function of adipose tissue: an update. T Ronti G Lupattelli E Mannarino, Clin Endocrinol (Oxf) 2006 64 355 365
12. Bone marrow adipocytes support dexamethasone-induced osteoclast differentiation. A Hozumi M Osaki H Goto K Sakamoto S Inokuchi H Shindo, Biochem Biophys Res Commun 2009 382 780 784
13. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. C Lara-Castro Y Fu BH Chung WT Garvey, Curr Opin Lipidol 2007 18 263 270 (Pubitemid 46743049)
14. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. MC Alessi M Poggi I Juhan-Vague, Curr Opin Lipidol 2007 18 240 245 (Pubitemid 46743045)
15. Risk factors for dysbaric osteonecrosis. K Miyanishi Y Kamo H Ihara T Naka M Hirakawa Y Sugioka, Rheumatology (Oxf) 2006 45 855 858 (Pubitemid 43985375)
16. Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis in patients with osteonecrosis of the femoral head. P Kang B Shen J Yang F Pei, Thromb Res 2008 123 367 373
17. Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. PJ Van Veldhuizen J Neff MD Murphey D Bodensteiner BS Skikne, Am J Hematol 1993 44 243 248 (Pubitemid 23328621)
18. Comparative analysis of serum proteomes: discovery of proteins associated with osteonecrosis of the femoral head. X Tan D Cai Y Wu B Liu L Rong Z Chen Q Zhao, Transl Res 2006 148 114 119 (Pubitemid 44287638)
19. Dexamethasone-induced plasminogen activator inhibitor-1 expression in human primary bone marrow adipocytes. A Hozumi M Osaki K Sakamoto H Goto T Fukushima H Baba H Shindo, Biomedical Research 2010 31 281 286
20. Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. G Motomura T Yamamoto K Miyanishi S Jingushi Y Iwamoto, Arthritis Rheum 2004 50 3387 3391 (Pubitemid 39372017)
21. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. JW Pritchett, Clin Orthop Relat Res 2001 173 178 (Pubitemid 32391291)
22. Effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. K Pengde G Hong P Fuxing S Bin Y Jing Z Zongke, Int J Exp Path 2010 91 235 243
23. Lovastatin inhibits adipogenesis and prevents osteonecrosis in steroid-treated rabbits. K Pengde P Fuxing S Bin Y Jing C Jingqiu, Joint Bone Spine 2008 75 696 701
24. Effects of glucocorticoid on adipocyte size in human bone marrow. M Kitajima M Shigematsu K Ogawa H Sugihara T Hotokebuchi, Med Mol Morphol 2007 40 150 156 (Pubitemid 47415943)
25. A novel semisynthesized small molecule icaritin reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid-deposition in a dose-dependent manner. G Zhang L Qin H Sheng XL Wang YX Wang DK Yeung JF Griffith XS Yao XH Xie ZR Li KM Lee KS Leung, Bone 2009 44 345 356
26. Pitavastatin may reduce risk of steroid-induced osteonecrosis in rabbits. K Nishida T Yamamoto G Motomura S Jingushi Y Iwamoto, Clin Orthop Relat Res 2008 466 1054 1058
27. The HMG-CoA reductase inhibitor rosuvastatin inhibits plasminogen activator inhibitor-1 expression and secretion in human adipocytes. H Laumen T Skurk H Hauner, Atherosclerosis 2008 196 565 573
28. Atorvastatin reduces plasminogen activator inhibitor-1 expression in adipose tissue of atherosclerotic rabbits. JQ Li SP Zhao QZ Li YC Cai LR Wu Y Fang P Li, Clin Chim Acta 2006 370 57 62 (Pubitemid 44080176)
29. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins. M Essig G Nguyen D Prie B Escoubet JD Sraer G Friedlander, Circ Res 1998 83 683 690 (Pubitemid 28462781)
30. Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells. RA Markle J Han BD Summers T Yokoyama KA Hajjar DP Hajjar AM Gotto Jr AC Nicholson, J Cell Biochem 2003 90 23 32 (Pubitemid 37052306)
31. HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells. Y Kunieda K Nakagawa H Nishimura H Kato N Ukimura S Yano H Kawano S Kimura M Nakagawa H Tsuji, Thromb Res 2003 110 227 234
32. Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1. Y Sato J Dong S Imagawa N Ishimori T Furumoto H Tsutsui BE Sobel S Fujii, Coron Artery Dis 2008 19 355 361
33. Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins. EK Kruithof, Thromb Haemost 2008 100 969 975
34. Lovastatin modulates in vivo and in vitro the plasminogen activator/plasmin system of rat proximal tubular cells: role of geranylgeranylation and Rho proteins. M Essig F Vrtovsnik G Nguyen JD Sraer G Friedlander, J Am Soc Nephrol 1998 9 1377 1388 (Pubitemid 28354547)
35. Inhibition of Rho/Rho-kinase signaling downregulates plasminogen activator inhibitor-1 synthesis in cultured human monocytes. T Ishibashi K Nagata H Ohkawara T Sakamoto K Yokoyama J Shindo K Sugimoto S Sakurada Y Takuwa T Teramoto Y Maruyama, Biochim Biophys Acta 2002 1590 123 130 (Pubitemid 34626775)
36. Effect of simvastatin on steroid-induced osteonecrosis evidenced by the serum lipid level and hepatic cytochrome P4503A in a rabbit model. K Iwakiri Y Oda Y Kaneshiro H Iwaki T Masada A Kobayashi A Asada K Takaoka, J Orthop Sci 2008 13 463 468
37. Low hepatic cytochrome P4503A activity is a risk for corticosteroid- induced osteonecrosis. Y Kaneshiro Y Oda K Iwakiri T Masada H Iwaki Y Hirota K Kondo K Takaoka, Clin Pharmacol Ther 2006 80 396 402 (Pubitemid 44479755)
38. Effects of simvastatin and pravastatin on 6 beta-hydroxycortisol excretion, a potential marker of cytochrome P-450 3A. Pharmacol Res. Y Horsmans JP Desager V van den Berge M Abrassart C Harvengt, 1993 28 243 248
39. Multihormonal control of ob gene expression and leptin secretion from cultured human visceral adipose tissue: increased responsiveness to glucocorticoids in obesity. CM Halleux I Servais BA Reul R Detry SM Brichard, J Clin Endocrinol Metab 1998 83 902 910 (Pubitemid 28496464)
40. Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. M Degawa-Yamauchi KA Moss JE Bovenkerk SS Shankar CL Morrison CJ Lelliott A Vidal-Puig R Jones RV Considine, Obes Res 2005 13 662 669